1. Biosimilar Datafile – New this edition!
Enjoy the practical benefits of a Microsoft Excel file containing data on biosimilar and biobetter drugs currently marketed or known to be in clinical development worldwide. Each drug can be seen in the context of data on their biologic reference products and content can readily be filtered on key indicators such as:
•Product Name/Development Code
•Stage of Development (US)
•Stage of Development (EU)
•EU Patent Expiry
•US Patent Expiry
•Brand Name (reference products)
•Sales Value (reference products)
Using the tables provided you can effortlessly drill down into the content to identify biosimilars/biobetters in development by country, company, ATC classification, stage of development therapeutic area. Better still, the data can easily be exported to your own analytics or competitive intelligence system.
2. Biosimilar Development Analysis Report
This completely updated and expanded report volume utilises the Datafile content to produce more than 200 clear tables, charts, graphs and maps to provide “at a glance” insights into high-level trends and significant developments. Areas covered include:
•Leading biosimilar companies - number of biosimilar products in portfolio
•Geographic distribution of biosimilar/biobetter research
•Biosimilar development pipelines by 14 compound class and therapy areas
•Biosimilar development pipelines by therapy area
•Biobetter developments by com
Copyright©2012 Vocus, Inc.
All rights reserved